Ondetti M A, Engel S L
J Med Chem. 1975 Jul;18(7):761-3. doi: 10.1021/jm00241a024.
Two new analogs of bradykinin, [8-beta-homophenylalanine]- and [7-beta-homoproline]bradykinin, have been synthesized by the solid-phase technique. In the anesthetized rat, [7-beta-HPro]bradykinin was equipotent with bradykinin and 30-100 times more potent than [8-beta-HPhe]bradykinin in vasodepressor activity. Both analogs were resistant to degradation in vitro by dipeptidylcarboxypeptidase from rabbit lung. Only the 7-beta-HPro analog seemed to be resistant to this type of degradation in vivo, since its hypotensive effect in the anesthetized rat was not potentiated by SQ 20881 (BPP9a), an inhibitor of dipeptidylcarboxypeptidase.
已通过固相技术合成了两种缓激肽新类似物,即[8-β-高苯丙氨酸]缓激肽和[7-β-高脯氨酸]缓激肽。在麻醉大鼠中,[7-β-HPro]缓激肽在血管降压活性方面与缓激肽等效,且比[8-β-HPhe]缓激肽强30至100倍。两种类似物在体外均对兔肺二肽基羧肽酶的降解具有抗性。只有7-β-HPro类似物在体内似乎对这种类型的降解具有抗性,因为其在麻醉大鼠中的降压作用未被二肽基羧肽酶抑制剂SQ 20881(BPP9a)增强。